Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Exec Chat: Philips' Connected Care & Health Informatics CEO On IT's Role In Tackling Health-Care Demands

Executive Summary

The role of digital technologies in enabling health-care providers to meet rising patient demands and overcome challenges is being increasingly recognized. Yet the health-care sector continues to lag behind other industries in adopting these technologies. CEO of Philips' Connected Care & Health Informatics businesses, Carla Kriwet, tells Medtech Insight what the group has been investing in and where it is innovating to accelerate this digital revolution in health care, and how it is staying ahead of new competition from the ICT sector in this digital health game.

You may also be interested in...



Philips' Compliance Monitoring Deal With Ypsomed Is A Chance To Profile HealthSuite Platform To Pharmas

Philips Healthcare and injection and infusion device-maker Ypsomed have teamed up to develop enhanced digital self-medication adherence monitoring services in a deal that should be confirmed imminently.

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.

Angle Files De Novo Submission For Parsortix System In Breast Cancer

The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel